Results: More than 80% of ESBL secretion bacteria in this study are susceptible to new generation broad spectrum antibiotics: Amikacin, Imipenem, Ticarcillin / Clavulanic acid, Meropenem, Piperacillin / Tazobactam, Neltimycin.